San Francisco, CA, United States of America

Elizabeth D Vo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Leidos Biomedical Research, Inc., University of California. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth D Vo. Retrieved from https://idiyas.com/inventor/elizabeth-d-vo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Elizabeth D Vo in Cancer Treatment

Introduction

Elizabeth D Vo is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of cancer research, particularly through her innovative work on K-Ras modulators. Her dedication to advancing medical science is evident in her patent portfolio.

Latest Patents

Elizabeth D Vo holds a patent for K-Ras inhibitors, which are crucial for developing treatments for cancer. The patent details compositions that comprise these inhibitors, showcasing her commitment to finding effective solutions for this devastating disease. She has 1 patent to her name, reflecting her innovative contributions to the field.

Career Highlights

Throughout her career, Elizabeth has worked with esteemed institutions such as the University of California and Leidos Biomedical Research, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in cancer research and development.

Collaborations

Elizabeth has had the opportunity to work alongside notable colleagues, including Frank McCormick and Adam Renslo. These collaborations have further enriched her research and contributed to her success in the field.

Conclusion

Elizabeth D Vo's work in developing K-Ras modulators exemplifies her dedication to cancer research and innovation. Her contributions are paving the way for new treatments that could significantly impact patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…